X. Peng

发表

Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells

Y. Li, Hong Liu, Xiaomei Peng, 2017, Renal failure.

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

R. Conley, K. Schuh, H. Ascher-Svanum, 2011, ClinicoEconomics and outcomes research : CEOR.

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting

J. Haro, M. Moneta, W. Montgomery, 2015, Patient preference and adherence.

Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin

J. Bae, Xiaomei Peng, O. Varnado, 2016, Patient preference and adherence.

Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

Ariel B. Lindner, Miroslav Radman, S. Hunt, 2008, Science.

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

L. Szczech, N. Chen, Jianghua Chen, 2019, The New England journal of medicine.

Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder?

J. Haro, R. Brugnoli, J. Aguado, 2015, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study

Z. Qin, Shao Lin, B. Shaw, 2020, Journal of the American College of Nutrition.

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients

J. Haro, J. Aguado, W. Montgomery, 2016, Neuropsychiatric disease and treatment.

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

R. Conley, H. Ascher-Svanum, D. Salkever, 2010, BMC psychiatry.

Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?

J. Haro, R. Brugnoli, M. Moneta, 2015, International journal of psychiatry in clinical practice.

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?

J. Haro, R. Brugnoli, Z. Kadziola, 2013, Patient preference and adherence.

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis

M. Valis, P. Huppke, A. Blaschek, 2021, Frontiers in Neurology.

Impact of painful physical symptoms on depression outcomes in elderly Asian patients

J. Haro, R. Brugnoli, Xiaomei Peng, 2014, International Psychogeriatrics.

Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review

K. Boye, T. Kennedy-Martin, X. Peng, 2017, Patient preference and adherence.

Long-term Evaluation of Opioid Treatment in Fibromyalgia

David A. Williams, K. Kroenke, P. Mease, 2015, The Clinical journal of pain.

Use of select medications prior to duloxetine initiation among commercially-insured patients

L. Boulanger, Xiaomei Peng, Shih-Yin Chen, 2012, Journal of pain research.

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

H. Ascher-Svanum, D. Faries, P. Haddad, 2009, BMC psychiatry.

Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study.

David A. Williams, K. Kroenke, P. Mease, 2013, Pain medicine.

Factors associated with and impact of pain persistence in Asian patients with depression: a 3-month, prospective observational study

J. Haro, J. Aguado, W. Montgomery, 2017, International journal of psychiatry in clinical practice.

The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study

I. Idris, Xiaomei Peng, K. van Brunt, 2018, Diabetes Therapy.

Direct Medical Costs and Medication Compliance among Fibromyalgia Patients: Duloxetine Initiators vs. Pregabalin Initiators

D. Faries, P. Sun, D. Novick, 2014, Pain practice : the official journal of World Institute of Pain.

Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.

H. Fu, H. Ascher-Svanum, A. Ali, 2016, Journal of managed care & specialty pharmacy.

Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study.

M. Tohen, H. Ascher-Svanum, B. Kinon, 2008, The Journal of clinical psychiatry.

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy

J. Kane, H. Ascher-Svanum, B. Kinon, 2011, ClinicoEconomics and outcomes research : CEOR.

Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study

Zhenxiang Zhao, S. Malmasi, W. Ge, 2021, Clinical Diabetes and Endocrinology.

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia

Christian R. Dolder, H. Ascher-Svanum, J. Lacro, 2008, Patient preference and adherence.

Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?

J. Haro, R. Brugnoli, Z. Kadziola, 2013, Journal of affective disorders.

A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection

N. Chen, Z. Ni, X. Lv, 2020, Annals of medicine.

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?

J. Haro, J. Aguado, W. Montgomery, 2015, Clinical practice and epidemiology in mental health : CP & EMH.

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

G. Marek, S. Iyengar, F. Vandenhende, 2010, European Neuropsychopharmacology.

PMH51 THE COST-EFFECTIVENESS OF EARLY RESPONDERS VERSUS EARLY NON-RESPONDERS TO ATYPICAL ANTIPSYCHOTIC THERAPY

J. Kane, H. Ascher-Svanum, B. Kinon, 2010 .

Utilization of duloxetine and celecoxib in osteoarthritis patients

Shih-Yin Chen, D. Novick, N. Wu, 2013, Current medical research and opinion.

Real‐world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

J. Haro, M. Moneta, W. Montgomery, 2016, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care

Shih-Yin Chen, D. Novick, N. Wu, 2013, Journal of pain research.

Antidepressant medication treatment patterns in Asian patients with major depressive disorder

J. Haro, R. Brugnoli, W. Montgomery, 2015, Patient preference and adherence.

Evaluating the impact of unmeasured confounding with internal validation data: an example cost evaluation in type 2 diabetes.

Karen Price, John W. Seaman, Douglas Faries, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Patient‐reported outcomes in a study of human regular U‐500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes

T. Ly, Xiaomei Peng, Trang T. Ly, 2020, Diabetes, obesity & metabolism.

A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy

Zhenxiang Zhao, W. Polonsky, M. Davies, 2019, Diabetes, obesity & metabolism.

Costs of treating patients with schizophrenia who have illness-related crisis events

H. Ascher-Svanum, D. Salkever, D. Faries, 2008, BMC psychiatry.

Clinicoeconomics and Outcomes Research Dovepress Cost-effectiveness of Early Responders versus Early Nonresponders to Atypical Antipsychotic Therapy

J. Kane, H. Ascher-Svanum, B. Kinon, 2022 .

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia

P. Sun, D. Novick, J. Andrews, 2014, Journal of pain research.